Table 3.
Age‐standardized DALY rates per 100 000 population | ||||
---|---|---|---|---|
Cardiovascular disease cause | 1990 | 2017 |
Average annual percentage change 1990‐2017 (%) |
Average annual percentage change 2010‐2017 (%) |
Cardiovascular diseases | 5264 (5143 to 5390) | 3159 (3047 to 3280) | −1.9 (−2 to −1.7) | −0.8 (−1.1 to −0.6) |
Ischemic heart disease | 2909 (2873 to 2962) | 1534 (1499 to 1572) | −2.3 (−2.5 to −2.2) | −1.1 (−1.4 to −0.8) |
Stroke | 1355 (1302 to 1405) | 827 (782 to 873) | −1.8 (−2 to −1.6) | −0.7 (−1.3 to −0.1) |
Cardiomyopathy and myocarditis | 196 (170 to 204) | 141 (134 to 156) | −1.2 (−1.4 to −1.1) | −0.6 (−1.1 to −0.2) |
Hypertensive heart disease | 191 (158 to 215) | 168 (134 to 186) | −0.5 (−0.6 to −0.4) | −0.3 (−0.5 to 0) |
Atrial fibrillation and flutter | 104 (85 to 126) | 108 (90 to 130) | 0.2 (0.1 to 0.2) | 0.1 (0.1 to 0.2) |
Rheumatic heart disease | 106 (100 to 114) | 56 (50 to 64) | −2.3 (−2.4 to −2.2) | −1.6 (−1.8 to −1.3) |
Aortic aneurysm | 82 (81 to 84) | 52 (50 to 53) | −1.7 (−1.8 to −1.6) | −0.5 (−0.8 to −0.2) |
Non‐rheumatic valvular heart disease | 52 (45 to 57) | 46 (40 to 50) | −0.5 (−0.5 to −0.4) | 0 (−0.1 to 0.1) |
Endocarditis | 39 (33 to 46) | 36 (32 to 45) | −0.2 (−0.4 to −0.1) | −0.1 (−0.4 to 0.3) |
Peripheral artery disease | 20 (12 to 29) | 31 (19 to 54) | 1.7 (1.6 to 1.8) | 1.2 (1.1 to 1.3) |
Other cardiovascular and circulatory diseases | 210 (190 to 236) | 161 (143 to 185) | −1 (−1 to −0.9) | −0.3 (−0.4 to −0.2) |
Cause‐specific cardiovascular diseases categories are sort ranked by magnitude of the burden measure in 2017. AAPC is considered statistically significant when its value is different from "zero" at alpha = 0.05, or zero value is not within the AAPC 95 UI limits. There is a constant trend when the zero value is within both 95% UI limits for the AAPC. There is an increasing or upward trend when both AAPC 95% UI limits are positive, and a decreasing or downward trend when both AAPC 95% UI limits are negative.